Journal of Otolaryngology and Ophthalmology of Shandong University ›› 2019, Vol. 33 ›› Issue (4): 31-35.doi: 10.6040/j.issn.1673-3770.1.2019.031

• Clinical Research • Previous Articles     Next Articles

Effects of dihydroartemisinin on endoreticulum stress pathway in FaDu hypopharyngeal carcinoma cells

Zelei HUANG1,Qi SONG2,Xiuying LU2,Lanzhen CUI2,Xiaoming LI2,*()   

  1. 1. Department of otolaryngology, Hebei General Hospital, Shijiazhuang 050057, Hebei, China
    2. Department of otolaryngology, Bethune International Peace Hospital, Shijiazhuang 050082, Hebei, China
  • Received:2019-05-13 Online:2019-07-16 Published:2019-07-22
  • Contact: Xiaoming LI E-mail:xmlmo@126.com

RichHTML

15

PDF (PC)

451

Abstract: Objective

To investigate the mechanism of inhibition by dihydroartemisinin (DHA) of the proliferation of FaDu cells in hypopharyngeal cancer, and provide a theoretical basis for its clinical application in anti-tumor therapy.

Methods

FaDu cells were cultured in different concentrations of glucose (5.5, 10, 15, 25, 50, 100 mM) for 36 h, then the expression of p-STAT3 and endoplasmic reticulum stress-related protein GRP78 were detected by western blot. FaDu cells of hypopharyngeal carcinoma were treated with DHA at different concentrations (10, 20, 40, 80, 160 M) in a culture medium with 25 mM glucose, and the effect on cell proliferation was detected by MTT assay 24 h later. Western blot was used to detect the expression of p-STAT3 and GRP78.

Results

DHA inhibited the proliferation of FaDu hypopharyngeal carcinoma cells in a concentration-dependent manner. Low-glucose concentration medium reduced the expression of p-STAT3 and increased the expression of GRP78. DHA inhibited the expression of p-STAT3; GRP78 expression was stimulated at low DHA concentrations, but was inhibited as the DHA concentration increased.

Conclusions

DHA significantly inhibits the proliferation of FaDu hypopharyngeal carcinoma cells, inhibits the expression of p-STAT3, and induces endoplasmic reticulum stress, which may be closely related to the interference of cellular glucose metabolism.

Key words: Dihydroartemisinin, Hypopharyngeal cance, Fadu cells, Endoreticulum stress

CLC Number: 

  • R739.6

Fig.1

Effects of different concentrations of DHA on FaDu cells after 24 h"

Fig.2

Effects of different concentrations of glucose medium on the expression of p-STAT3, STAT3, and GRP78"

Fig.3

Effects of different concentrations of DHA on the expression of p-STAT3, STAT3, and GRP78"

1 Heng PS , Irfan M . Hypopharyngeal cancer masquerading as a thyroid mass[J]. Med J Malaysia, 2016, 71 (6): 360- 362.
2 Takes RP , Strojan P , Silver CE , et al. Current trends in initial management of hypopharyngeal cancer: the declining use of open surgery[J]. Head Neck, 2012, 34 (2): 270- 281.
doi: 10.1002/hed.21613
3 Cooper JS , Porter K , Mallin K , et al. National Cancer Database report on cancer of the head and neck: 10-year update[J]. Head Neck, 2009, 31 (6): 748- 758.
doi: 10.1002/hed.21022
4 Day D , Hansen AR , Siu LL . Hypopharyngeal cancer: looking back, moving forward[J]. Curr Oncol, 2016, 23 (4): 221- 222.
doi: 10.3747/co.23.3242
5 Wang DC , Meng G , Zheng MH , et al. The glutaminase-1 inhibitor 968 enhances dihydroartemisinin-mediated antitumor efficacy in hepatocellular carcinoma cells[J]. PLoS One, 2016, 11 (11): e0166423.
doi: 10.1371/journal.pone.0166423
6 Jiang J , Geng GJ , Yu XY , et al. Repurposing the anti-malarial drug dihydroartemisinin suppresses metastasis of non-small-cell lung cancer via inhibiting NF-κB/GLUT1 axis[J]. Oncotarget, 2016, 7 (52): 87271- 87283.
doi: 10.18632/oncotarget.13536.10.1007/s10637-010-9481-8
7 Lu JJ , Chen SM , Zhang XW , et al. The anti-cancer activity of dihydroartemisinin is associated with induction of iron-dependent endoplasmic reticulum stress in colorectal carcinoma HCT116 cells[J]. Invest New Drugs, 2011, 29 (6): 1276- 1283.
doi: 10.1007/s10637-010-9481-8
8 Zhang SQ , Ma YN , Jiang JT , et al. Inhibition of urokinase-type plasminogen activator expression by dihydroartemisinin in breast cancer cells[J]. Oncol Lett, 2014, 7 (5): 1375- 1380.
doi: 10.3892/ol.2014.1918
9 Hu CJ , Zhou L , Cai Y . Dihydroartemisinin induces apoptosis of cervical cancer cells via upregulation of RKIP and downregulation of bcl-2[J]. Cancer Biol Ther, 2014, 15 (3): 279- 288.
doi: 10.4161/cbt.27223
10 Xu G , Zou WQ , Du SJ , et al. Mechanism of dihydroartemisinin-induced apoptosis in prostate cancer PC3 cells: An iTRAQ-based proteomic analysis[J]. Life Sci, 2016, 157: 1- 11.
doi: 10.1016/j.lfs.2016.05.033
11 Jia LF , Song Q , Zhou CY , et al. Dihydroartemisinin as a putative STAT3 inhibitor, suppresses the growth of head and neck squamous cell carcinoma by targeting Jak2/STAT3 signaling[J]. PLoS One, 2016, 11 (1): e0147157.
doi: 10.1371/journal.pone.0147157
12 贾立峰, 李晓明, 申宇鹏, 等. 双氢青蒿素对下咽癌Fadu细胞凋亡的影响[J]. 临床耳鼻咽喉头颈外科杂志, 2016, 30 (21): 1685- 1688.
doi: 10.13201/j.issn.1001-1781.2016.21.005
JIA Lifeng , LI Xiaoming , SHEN Yupeng , et al. Effects of dihydroartemisinin on the apoptosis of Fadu cells[J]. Journal of Clinical Otorhinolaryngology Head and Neck Surgery, 2016, 30 (21): 1685- 1688.
doi: 10.13201/j.issn.1001-1781.2016.21.005
13 Pi LH , Li XM , Song Q , et al. Knockdown of glucose-regulated protein 78 abrogates chemoresistance of hypopharyngeal carcinoma cells to cisplatin induced by unfolded protein in response to severe hypoxia[J]. Oncol Lett, 2014, 7 (3): 685- 692.
doi: 10.3892/ol.2013.1753
14 Teng Y , Ross JL , Cowell JK . The involvement of JAK-STAT3 in cell motility, invasion, and metastasis[J]. JAKSTAT, 2014, 3 (1): e28086.
doi: 10.4161/jkst.28086
15 Kamran MZ , Patil P , Gude RP . Role of STAT3 in cancer metastasis and translational advances[J]. Biomed Res Int, 2013, 2013: 421821.
doi: 10.1155/2013/421821
16 Lopez R , Arumugam A , Joseph R , et al. Hyperglycemia enhances the proliferation of non-tumorigenic and malignant mammary epithelial cells through increased leptin/IGF1R signaling and activation of AKT/mTOR[J]. PLoS One, 2013, 8 (11): e79708.
doi: 10.1371/journal.pone.0079708
17 Wallbillich JJ , Josyula S , Saini U , et al. High glucose-mediated STAT3 activation in endometrial cancer is inhibited by metformin: therapeutic implications for endometrial cancer[J]. PLoS One, 2017, 12 (1): e0170318.
doi: 10.1371/journal.pone.0170318
18 Kaira K , Toyoda M , Shimizu A , et al. Prognostic significance of GRP78/BiP expression in patients with Stage Ⅲ/Ⅳ hypopharyngeal squamous cell carcinoma[J]. Neoplasma, 2016, 63 (3): 477- 483.
doi: 10.4149/319_151002N513
19 Niu ZY , Wang MY , Zhou L , et al. Elevated GRP78 expression is associated with poor prognosis in patients with pancreatic cancer[J]. Sci Rep, 2015, 5: 16067.
doi: 10.1038/srep16067
20 Wang XH , Liu BR , Qu B , et al. Silencing STAT3 may inhibit cell growth through regulating signaling pathway, telomerase, cell cycle, apoptosis and angiogenesis in hepatocellular carcinoma: potential uses for gene therapy[J]. Neoplasma, 2011, 58 (2): 158- 171.
doi: 10.4149/neo_2011_02_158
[1] YANG Ming, LIU Xuexia, ZHANG Hua. Progress of m6A recognition protein IGF2BPs in head and neck cancer [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(3): 153-161.
[2] CHENG Yao, ZHANG Zhen, YANG Ji, FENG Chengmin, DENG Qicheng, ZHANG Xi, ZHAO Rui, ZHU Xin, WU Junzhi, LIU Hai, DENG Shishan. Expression and clinical significance of CIP2A in hypopharyngeal carcinoma [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2022, 36(2): 40-44.
[3] . Curcumin combined with resveratrol enhances their anti-tumoral effects in the head and neck carcinoma. [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2017, 31(2): 67-72.
[4] LI Xiaoming, SONG Qi, LI Hongxia, TAO Zhenfeng, SHEN Yupeng, XIAO Shufen. Reconstruction of hypopharyngeal defects after ablation of advanced head and neck squamous carcinoma involving hypophaynx with pectoralis major myocutaneous flap. [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2016, 30(3): 4-9.
[5] DONG Pin, YING Xinjiang, CHEN Xinwei, DENG Zhihong, ZHANG Shaoqiang, YU Ziwei, JIN Bin, SUN Zhenfeng, XIE Jin, ZHU Jiangcai. Preliminary clinical analysis of neo-adjuvant chemotherapy with nimotuzumab plus nedaplatin and fluorouracil in hypopharyngeal squamous cell carcinoma. [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2016, 30(3): 10-14.
[6] LI Wenming, WEI Dongmin, SUN Ruijie, QIAN Ye, LIU Dayu, XIE Guang, LEI Dapeng, PAN Xinliang. Surgical treatment of hypopharyngeal cancer with cervical esophageal invasion. [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2016, 30(3): 15-19.
[7] HU Wenliang, ZHENG Yanqiu, CUI Xiaobo, CUI Yanru, SUN Yuanhao. Bioinformatic screening of differentially expressed protein kinases and their inhibitors in hypopharyngeal cancer. [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2016, 30(3): 24-28.
[8] ZHENG Li-you. null [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2012, 26(6): 31-33.
[9] LIANG Hui1,2, PAN Xinliang1, MA Chao3, WANG Qirong2, HAN Fei2, CUI Zhaoyang2. Invasion of the CD133-positive cells in FADU cell line [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2010, 24(2): 5-7.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
No Suggested Reading articles found!
Website Copyright: Editorial Office of Journal of Otolaryngology and Ophthalmology of Shandong University
Address: No.27 Shanda South Road, Jinan, Shandong, China. Post code: 250100 Tel: +86-0531-88366912 Email: ebhxb@sdu.edu.cn Supported by Beijing Magtech Co.Ltd